Kyverna Therapeutics, Inc. announced that it expects to receive $25 million in funding from Vida Ventures Advisors, LLC, Westlake Village BioPartners, Gilead Sciences, Inc.
On the same date company received $25 million in its first tranche.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
63.9 USD | +0.04% | -0.20% | -21.06% |
1st Jan change | Capi. | |
---|---|---|
-21.06% | 79.59B | |
+43.36% | 749B | |
+39.42% | 605B | |
-6.69% | 351B | |
+18.87% | 328B | |
+8.05% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.31% | 167B | |
+6.58% | 165B |